United States
Germany
Japan
United Kingdom
China
Mouse Monoclonal NAK Antibody (108A429)
| Applications | ICC/IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat, Bovine, Canine |
TA336453 is a replacement of AM08296PU-N.
Antibodies
CNY 5,973.00
5周
SRC (N-term) (incl. pos. control) mouse monoclonal antibody, clone 11F1, Purified
| Applications | ELISA, WB |
| Reactivities | Canine, Human, Mouse, Rat |
Mouse Monoclonal cleaved ROCK1 Antibody (154C1465)
| Applications | ICC/IF, WB |
| Reactivities | Human, Mouse, Rat, Canine, Primate, Rabbit |
CNY 5,973.00
5周
MEK1 (MAP2K1) (incl. pos. control) mouse monoclonal antibody, clone 9G3, Purified
| Applications | ELISA, WB |
| Reactivities | Canine, Human, Mouse, Rat |
CNY 5,973.00
5周
Aurora A (AURKA) (N-term) (incl. pos. control) mouse monoclonal antibody, clone 7F12, Purified
| Applications | WB |
| Reactivities | Canine, Human, Mouse, Rat |
PAK4 (incl. pos. control) mouse monoclonal antibody, clone 6C1, Purified
| Applications | WB |
| Reactivities | Canine, Human, Mouse, Rat |
CNY 5,973.00
5周
ERK2 (MAPK1) (C-term) (incl. pos. control) mouse monoclonal antibody, clone 6G11, Biotin
| Applications | ELISA, IP, WB |
| Reactivities | Canine, Human, Mouse, Rat |
CNY 5,973.00
5周
ERK2 (MAPK1) (N-term) (incl. pos. control) mouse monoclonal antibody, clone 6H3, Biotin
| Applications | ELISA, WB |
| Reactivities | Canine, Human, Mouse, Rat |
CNY 6,798.00
5周
Her2 (ERBB2) pTyr1112 (incl. pos. control) mouse monoclonal antibody, clone 19G5, Biotin
| Applications | IF, WB |
| Reactivities | Canine, Human, Mouse, Rat |
CNY 6,798.00
5周
Her2 (ERBB2) (1240-1260) (incl. pos. control) mouse monoclonal antibody, clone 19D2, Biotin
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
活动过滤器
优化搜索结果
Category
Target Symbol
Antibody Hosts
Conjugates
Isotypes
Assay Types
Pathways
- Focal adhesion (9)
- ErbB signaling pathway (8)
- Non-small cell lung cancer (6)
- Pathways in cancer (6)
- Adherens junction (5)
- Bladder cancer (5)
- Endometrial cancer (5)
- Gap junction (5)
- GnRH signaling pathway (5)
- Pancreatic cancer (5)
- Prostate cancer (5)
- Regulation of actin cytoskeleton (5)
- VEGF signaling pathway (5)
- Vascular smooth muscle contraction (5)
- Axon guidance (4)
- Chemokine signaling pathway (4)
- Fc epsilon RI signaling pathway (4)
- Fc gamma R-mediated phagocytosis (4)
- Glioma (4)
- Long-term depression (4)
- Long-term potentiation (4)
- MAPK signaling pathway (4)
- Melanogenesis (4)
- Natural killer cell mediated cytotoxicity (4)
- Oocyte meiosis (4)
- Renal cell carcinoma (4)
- T cell receptor signaling pathway (4)
- Toll-like receptor signaling pathway (4)
- Acute myeloid leukemia (3)
- B cell receptor signaling pathway (3)
- Calcium signaling pathway (3)
- Chronic myeloid leukemia (3)
- Colorectal cancer (3)
- Dorso-ventral axis formation (3)
- Insulin signaling pathway (3)
- Melanoma (3)
- Neurotrophin signaling pathway (3)
- Prion diseases (3)
- Progesterone-mediated oocyte maturation (3)
- TGF-beta signaling pathway (3)
- Thyroid cancer (3)
- Alzheimer's disease (2)
- Leukocyte transendothelial migration (2)
- NOD-like receptor signaling pathway (2)
- Pathogenic Escherichia coli infection (2)
- Tight junction (2)
- Type II diabetes mellitus (2)
- Wnt signaling pathway (2)
- mTOR signaling pathway (2)
- Cytosolic DNA-sensing pathway (1)
- Endocytosis (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Phosphatidylinositol signaling system (1)
- RIG-I-like receptor signaling pathway (1)
- Vibrio cholerae infection (1)
